Market Fraud Suits Should Be Covered, Pharma Co. Says
By Jennifer Mandato · September 5, 2023, 10:06 PM EDT
A pharmaceutical company told a Delaware federal court that several lawsuits brought against it by stockholders following a subpoena and investigation by the U.S. Securities and Exchange Commission should be deemed...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login